Ohya, S., Matsui, M. and Kajikuri, J. (2020) “Ca 2+ -Activated K + Channel K Ca 3.1 as a Double-Edged Sword in the Treatment of Inflammatory Bowel Disease”, Journal of Gastrointestinal and Liver Diseases, 29(4), pp. 487–489. doi: 10.15403/jgld-3234.